ST Wenming: Tianjin Wenming has been subjected to other risk warnings.

ST Announcement, the controlling subsidiary of the company, Tianjin Weiming Biopharmaceutical Co., Ltd., has been subjected to temporary suspension of production and sales risk control measures, and is expected to be unable to resume normal production and business activities within three months, which violates relevant regulations of the Shenzhen Stock Exchange's Stock Listing Rules. Starting from July 8, 2025, other risk warnings will be implemented, and the stock abbreviation will be changed to "ST Weiming", with a daily trading limit of 5%.